DE-122
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for DE-122, covering 2020-01-14 to 2021-07-13. Get the full timeline:
Most recent: Clinical Trial Update: Study Assessing the Efficacy and Safety of Intravitreal Injections of DE-122 in Combination With Lucentis® Compared to Lucentis® Monotherapy in Wet Age-related Macular Degeneration Subjects [Phase 2]